A Gastroenterologist’ clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.

References

• Yuen KS, Ye ZW, Fung SY, et al. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci. 2020;10(1):40. .
   PubMed Web of Science ®Google Scholar
• Remuzzi A, Remuzzi GCOVID-19. COVID-19 and Italy: what next? Lancet. 2020 Apr 11;395(10231):1225–1228.
   PubMed Web of Science ®Google Scholar
• Bernard Stoecklin S, Rolland P, Silue Y, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020;25:6.
   Google Scholar
• Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ. 2020 Mar;12(368):m1036.
   Web of Science ®Google Scholar
• He F, Deng Y, Li W. Coronavirus disease 2019: what we know? J Med Virol. 2020 Jul;92(7):719–725.
   PubMed Web of Science ®Google Scholar
• Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020 Aug;288(2):192–206.
   PubMed Web of Science ®Google Scholar
• Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95.
   PubMed Web of Science ®Google Scholar
• Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 May;109(5):531–538.
   PubMed Web of Science ®Google Scholar
• Jiang F, Deng L, Zhang L, et al. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med. 2020 May;35(5):1545–1549.
   PubMed Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Lancet Public Health T. COVID-19 in Spain: a predictable storm? Lancet Public Health. 2020 Nov;5(11):e568.
   PubMed Web of Science ®Google Scholar
• Danese S, Ran ZH, Repici A, et al. Gastroenterology department operational reorganisation at the time of covid-19 outbreak: an Italian and Chinese experience. Gut. 2020 Jun;69(6):981–983. .
   PubMed Web of Science ®Google Scholar
• Ciceri F, Ruggeri A, Lembo R, et al. Decreased in-hospital mortality in patients with COVID-19 pneumonia. Pathog Glob Health. 2020 Sep;114(6):281–282. .
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Rees EM, Nightingale ES, Jafari Y, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020 Sep 3;18(1):270.
   PubMed Web of Science ®Google Scholar
• Ji JS, Liu Y, Liu R, et al. Survival analysis of hospital length of stay of novel coronavirus (COVID-19) pneumonia patients in Sichuan, China. medRxiv. 2020.
   Google Scholar
• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 — final Report. N Engl J Med. 2020 Oct 8;383(19):1813–1826.
   Web of Science ®Google Scholar
• Shang L, Zhao J, Hu Y, et al. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020 Feb 29;395(10225):683–684.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Murthy S, Diaz JV, et al. Group WHOREAfC-TW. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020Oct6;324(13):1330–1341.
   PubMed Web of Science ®Google Scholar
• Rc G, Horby P, WS L, et al. Dexamethasone in hospitalized patients with Covid-19N Engl J Med. 2021 Feb 25;384(8):693-704..
   Web of Science ®Google Scholar
• Rodriguez-Bano J, Pachon J, Carratala J, et al. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19). Clin Microbiol Infect. 2021 Feb;27(2):244-252.
   Web of Science ®Google Scholar
• Rojas-Marte G, Khalid M, Mukhtar O, et al. Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case–controlled study. QJM. 2020 Aug 1;113(8):546–550.
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Meschiari M, Cozzi-Lepri A, et al. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug;2(8):e474–e484. .
   PubMedGoogle Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: summary of a Report of 72314 Cases From the Chinese center for disease control and prevention. JAMA. 2020 Apr 7;323(13):1239–1242.
   PubMed Web of Science ®Google Scholar
• Covino M, De Matteis G, Burzo ML, et al. Predicting in-hospital mortality in COVID −19 Older patients with specifically developed scores. J Am Geriatr Soc. 2021 Jan;69(1):37–43. .
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934–943.
   PubMed Web of Science ®Google Scholar
• Mendes A, Serratrice C, Herrmann FR, et al. Predictors of in-hospital mortality in older patients with COVID-19: the COVIDAge study. J Am Med Dir Assoc. 2020 Nov;21(11):1546–1554 e3. .
   PubMed Web of Science ®Google Scholar
• Rosenbaum L. Facing Covid-19 in Italy — ethics, logistics, and therapeutics on the epidemic’s front line. N Engl J Med. 2020 May 14;382(20):1873–1875.
   PubMed Web of Science ®Google Scholar
• Hughes MT, Kahn J, Kachalia A. Who Goes First? Government Leaders and Prioritization of SARS-CoV-2 Vaccines. N Engl J Med. 2021 Feb 4;384(5):e15.
   PubMed Web of Science ®Google Scholar